DXB
DIMERIX FPO [DXB]
Healthcare · ASX Small Cap
$0.2400 +2.1%
Updated 14 Jul 2026 · Signals refresh every scan
Get alerts when DXB triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Watch out — volume is flowing out even as price holds up. Distribution pattern
- Beating the Small Ords index — relative strength of 1.36, so it's outpacing the pack
- Cash positive / operating cashflow positive
- 4C filed 2026-04-29
- Strong revenue growth (+636%)
- EPS estimates revised upward (+10pts)
- Near 52-week low (15% of range)
- Sentiment is mixed — no strong consensus either way
- This one has been in freefall — down 64% over the past year
- Revenue growing at +636% — the top line is moving in the right direction
- Beneish M-Score 7.74 > -1.78: likely earnings manipulation
- RBA hiking (-3pts)
Risk Signals
- Below the 200-day average — the long-term trend is still working against it
- Deeply negative margins (-220%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- The bigger volume days are the down days — volume-weighted momentum is negative (-2.44%/day)
Ask Scout AI about DXB
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE DMX-200 Available To Patients Via Post-Trial Access Pathways
NONE Dimerix Investor Webinar
NONE Dimerix Licenses DMX200 to Everest for China and Asia Region
NEGATIVE Trading Halt
Recent ASX Announcements
| 2026-07-08 | DMX-200 Available To Patients Via Post-Trial Access Pathways PRICE SENSITIVE |
| 2026-06-16 | Dimerix Investor Webinar |
| 2026-06-16 | Dimerix Licenses DMX200 to Everest for China and Asia Region PRICE SENSITIVE |
| 2026-06-14 | Trading Halt PRICE SENSITIVE |
Key Metrics
$141.1M
Market Cap
3.2M
Avg Volume
0.5x
Vol Ratio
$0.16 — $0.67
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-594.5%
ROE
-219.9%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 78% |
| L | Leader vs Laggard | laggard | RS: -22 |
| I | Institutional Sponsorship | weak | Inst: 3% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
109 tickers in this sector
View all Healthcare signals →Track DXB and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required